Content by The Alliance for Clinical Trials in Oncology

|2 min read

Pembrolizumab Shows Positive Results in Bladder Cancer Trial

Globally, there were around 573,000 new cases and 212,000 deaths from bladder cancer in 2020
|2 min read

Bladder Cancer Treatment in Phase 3 Trial Shows Promise

It is estimated that approximately 82,290 people in the US will be diagnosed with bladder cancer in 2023 
|3 min read

Phase 3 Trial for Neuroendocrine Tumor Treatment Shows Promise

The safety profile of cabozantinib observed in the trial was consistent with its known safety profile
Page 1 of 1